Scarica l'app Stockscreener
2.28
2.15%
-0.05
Dopo l'orario di chiusura:
2.29
0.01
+0.44%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Casi Pharmaceuticals Inc Borsa (CASI) Ultime notizie
Can volume confirm reversal in CASI Pharmaceuticals Inc.Market Trend Report & High Return Trade Guides - Newser
What to expect from CASI Pharmaceuticals Inc. in the next 30 daysBear Alert & Weekly Top Gainers Alerts - Newser
CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference - ACCESS Newswire
Volatility clustering patterns for CASI Pharmaceuticals Inc.Portfolio Risk Report & Risk Controlled Swing Trade Alerts - Newser
Risk vs reward if holding onto CASI Pharmaceuticals Inc.2025 Growth vs Value & Technical Pattern Based Buy Signals - Newser
Best data tools to analyze CASI Pharmaceuticals Inc. stockPortfolio Growth Summary & Weekly Breakout Watchlists - Newser
Is CASI Pharmaceuticals Inc. a momentum stockJuly 2025 Patterns & Expert Approved Momentum Ideas - khodrobank.com
Using RSI to spot recovery in CASI Pharmaceuticals Inc.July 2025 Setups & Low Risk Profit Maximizing Plans - Newser
Will CASI Pharmaceuticals Inc. rebound enough to break evenTrade Ideas & Free Verified High Yield Trade Plans - Newser
What Fibonacci levels say about CASI Pharmaceuticals Inc. reboundWall Street Watch & Safe Capital Growth Tips - Newser
CASI Pharmaceuticals Faces Setback with FOLOTYN® License Expiration in China - MSN
Advanced analytics toolkit walkthrough for CASI Pharmaceuticals Inc.Portfolio Gains Report & Safe Swing Trade Setups - Newser
What Technical Tools Say About CASI Pharmaceuticals Inc. RecoveryJuly 2025 EndofMonth & Risk Adjusted Buy/Sell Alerts - beatles.ru
Does CASI Pharmaceuticals Inc. have consistent dividend growthWeekly Trend Report & AI Driven Price Predictions - khodrobank.com
CASI Pharmaceuticals Strengthens Board with New Appointment - TipRanks
CASI Pharmaceuticals Appoints Barbara Krebs-Pohl, PhD to Board of Directors - ACCESS Newswire
$2.9B Novartis Deal Expert: CASI Pharma Appoints MorphoSys Ex-CBO to Guide CID-103 Development - Stock Titan
What are CASI Pharmaceuticals Inc.’s recent SEC filings showingMarket Growth Report & Low Drawdown Trading Strategies - خودرو بانک
What drives CASI Pharmaceuticals Inc.’s stock priceWeekly Investment Recap & Real-Time Buy Signal Alerts - khodrobank.com
Is CASI Pharmaceuticals Inc. attractive for institutional investorsMarket Activity Report & AI Enhanced Trade Execution Alerts - khodrobank.com
Candlestick signals on CASI Pharmaceuticals Inc. stock todayJuly 2025 Sentiment & Stepwise Trade Execution Plans - Newser
Can CASI Pharmaceuticals Inc. grow without external funding2025 Earnings Surprises & Growth Focused Entry Point Reports - khodrobank.com
Ranking CASI Pharmaceuticals Inc. among high performing stocks via toolsMarket Volume Report & Technical Entry and Exit Tips - Newser
Combining price and volume data for CASI Pharmaceuticals Inc.July 2025 Gainers & Safe Entry Trade Signal Reports - Newser
How to build a custom watchlist for CASI Pharmaceuticals Inc.July 2025 Recap & Daily Price Action Insights - Newser
Does CASI Pharmaceuticals Inc. show high probability of reboundMarket Performance Recap & Growth Focused Stock Pick Reports - Newser
Using data tools to time your CASI Pharmaceuticals Inc. exitIndex Update & AI Forecasted Entry and Exit Points - Newser
There's No Escaping CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Muted Revenues Despite A 79% Share Price Rise - 富途牛牛
Custom watchlist performance reports with CASI Pharmaceuticals Inc.Gap Down & Low Risk Growth Stock Ideas - Newser
CASI Pharmaceuticals Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Is CASI Pharmaceuticals Inc. forming a reversal patternShare Buyback & Daily Volume Surge Trade Alerts - Newser
Institutional Tools Highlight Unusual Flow in CASI Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Quantitative breakdown of CASI Pharmaceuticals Inc. recent moveEarnings Growth Summary & Stepwise Swing Trade Plans - Newser
Long term hold vs stop loss in CASI Pharmaceuticals Inc.Options Play & AI Powered Market Entry Strategies - Newser
CASI Pharmaceuticals 2025 Q2 Earnings Wider Losses Despite Revenue Growth - AInvest
Can trapped investors hope for a rebound in CASI Pharmaceuticals Inc.Gold Moves & Daily Profit Focused Stock Screening - Newser
Can a trend reversal in CASI Pharmaceuticals Inc. lead to recoveryJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
CASI Pharmaceuticals Reports Q2 2025 Results and Strategic Asset Divestiture - MSN
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):